Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Jon C. Ogg | Dec 30, 2014 at 7:45 AM EST

The Best Performing Biotech Stocks of 2014: Amazing 300% Gainers

Out of 28 biotech stocks with market capitalization rates north of $300 million that were up 100% or more in…

Chris Lange | Dec 29, 2014 at 1:55 PM EST

Flex Pharma Files for IPO

Flex Pharma Inc. has filed with the Securities and Exchange Commission (SEC) for its initial public offering.

Chris Lange | Dec 29, 2014 at 10:45 AM EST

Is Gilead Already Coming Back Into Favor?

Is it possible that Gilead Sciences is already coming back into favor after just a week of being in the…

Lee Jackson | Dec 29, 2014 at 10:05 AM EST

5 Top Pharmaceutical Stock Picks for 2015

In a new research report, the SunTrust Robinson Humphrey team highlights the top pharmaceutical stocks to buy for 2015.

Chris Lange | Dec 23, 2014 at 12:15 PM EST

Analysts Predict Big Value Trap for Gilead Investors

Analysts are beginning to make their calls for what the future will hold for Gilead Sciences, AbbVie and Express Scripts.

Lee Jackson | Dec 23, 2014 at 9:50 AM EST

RBC’s 5 Top Biotech Stocks to Buy for 2015

One sector that could be poised to do well could be the biotech arena, and the team at RBC has…

Chris Lange | Dec 22, 2014 at 1:20 PM EST

What the AbbVie and Express Script Deal Means for Gilead

AbbVie and Express Scripts have entered into an exclusive agreement under which Express Scripts will distribute AbbVie's hepatitis treatment.

Chris Lange | Dec 19, 2014 at 2:58 PM EST

Merrill Lynch’s Top Health Care Stock Picks for 2015

24/7 Wall St. has compiled a list health care stocks that Merrill Lynch expects to be top performers in 2015.

Chris Lange | Dec 19, 2014 at 11:15 AM EST

Juno, the Last IPO of 2014, Enters the Market With a Bang

Juno Therapeutics debuted on the market Friday morning and has made a big splash.

Douglas A. McIntyre | Dec 19, 2014 at 6:34 AM EST

Nurses Are the Most Trusted People in America

Nurses are the most trusted workers in America, based on honesty and ethical standards. Doctors come in second.

Jon C. Ogg | Dec 17, 2014 at 1:05 PM EST

Is a Biosimilar (Generic) Top Cancer Drug for You?

A biosimilar application filing from Apotex has been accepted by the Food and Drug Administration for version of Amgen's Neulasta.

Chris Lange | Dec 17, 2014 at 9:55 AM EST

Are Volcano Shareholders Getting Enough in the Buyout?

Guided therapy tools maker Volcano has announced that it has entered into a definitive agreement to be acquired by Koninklijke…

Douglas A. McIntyre | Dec 11, 2014 at 6:25 AM EST

43 Million Americans Have Unpaid Medical Bills

According to a new study from the Consumer Financial Protection Bureau, 42.9 million Americans have unpaid medical bills.

Jon C. Ogg | Dec 10, 2014 at 10:35 AM EST

What a Generic Celebrex Means for Pfizer and for Actavis

While this was generally a known event coming down the pipe, arthritis drug Celebrex now has a generic competitor in…

Chris Lange | Dec 10, 2014 at 10:00 AM EST

Are Investors Signaling Optimism in Biotechs Through Short Interest?

The short interest data are out for the November 28 settlement date, and 24/7 Wall St. has reviewed the top…

1 … 273 274 275 276 277 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

The Best Performing Biotech Stocks of 2014: Amazing 300% Gainers

Flex Pharma Files for IPO

Is Gilead Already Coming Back Into Favor?

5 Top Pharmaceutical Stock Picks for 2015

Analysts Predict Big Value Trap for Gilead Investors

RBC’s 5 Top Biotech Stocks to Buy for 2015

What the AbbVie and Express Script Deal Means for Gilead

Merrill Lynch’s Top Health Care Stock Picks for 2015

Juno, the Last IPO of 2014, Enters the Market With a Bang

Nurses Are the Most Trusted People in America

Is a Biosimilar (Generic) Top Cancer Drug for You?

Are Volcano Shareholders Getting Enough in the Buyout?

43 Million Americans Have Unpaid Medical Bills

What a Generic Celebrex Means for Pfizer and for Actavis

Are Investors Signaling Optimism in Biotechs Through Short Interest?

Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

Spirit Airlines Shuts Down After Final Flight Landed on Saturday

Don’t Fly To Buffalo Or LA

Bitcoin Price: BTC Is Up 19% in 30 Days — Is the Bear Market Officially Over?

Ben Carlson Calls Out the Goldman Survey That Says 40% of $500K Earners Live Paycheck-to-Paycheck. The Definition Is the Problem.

I Have $7.5 Million in a Traditional IRA at 60 — How Aggressively Should I Do Roth Conversions?

Texas Instruments or ON Semiconductor: Which Analog Chip Stock Won in April?

Spirit Airlines Shuts Down After Final Flight Landed on Saturday

Health and Healthcare Articles

All Health and Healthcare Articles

The Best Performing Biotech Stocks of 2014: Amazing 300% Gainers

Flex Pharma Files for IPO

Is Gilead Already Coming Back Into Favor?

5 Top Pharmaceutical Stock Picks for 2015

Analysts Predict Big Value Trap for Gilead Investors

RBC’s 5 Top Biotech Stocks to Buy for 2015

What the AbbVie and Express Script Deal Means for Gilead

Merrill Lynch’s Top Health Care Stock Picks for 2015

Juno, the Last IPO of 2014, Enters the Market With a Bang

Nurses Are the Most Trusted People in America

Is a Biosimilar (Generic) Top Cancer Drug for You?

Are Volcano Shareholders Getting Enough in the Buyout?

43 Million Americans Have Unpaid Medical Bills

What a Generic Celebrex Means for Pfizer and for Actavis

Are Investors Signaling Optimism in Biotechs Through Short Interest?

Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

Spirit Airlines Shuts Down After Final Flight Landed on Saturday

Don’t Fly To Buffalo Or LA

Bitcoin Price: BTC Is Up 19% in 30 Days — Is the Bear Market Officially Over?

Featured Reads

Ben Carlson Calls Out the Goldman Survey That Says 40% of $500K Earners Live Paycheck-to-Paycheck. The Definition Is the Problem.

I Have $7.5 Million in a Traditional IRA at 60 — How Aggressively Should I Do Roth Conversions?